Cargando…
Relative Dose Intensity and Pathologic Response Rates in Patients With Breast Cancer and With and Without HIV Who Received Neoadjuvant Chemotherapy
Patients who are HIV-positive and have breast cancer have worse overall survival (OS) compared with patients who are HIV-negative. Pathologic complete response (pCR) and relative dose intensity (RDI) of chemotherapy are associated with survival. We assessed whether pCR and RDI rates were lower for p...
Autores principales: | Martei, Yehoda M., Narasimhamurthy, Mohan, Setlhako, Dipho I., Ayane, Gezahen, Ralefala, Tlotlo, Chiyapo, Sebathu, Gross, Robert, Shulman, Lawrence N., Grover, Surbhi, DeMichele, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173574/ https://www.ncbi.nlm.nih.gov/pubmed/35584347 http://dx.doi.org/10.1200/GO.22.00016 |
Ejemplares similares
-
Impact of Essential Medicine Stock Outs on Cancer Therapy Delivery in a Resource-Limited Setting
por: Martei, Yehoda M., et al.
Publicado: (2019) -
Retrospective cohort analysis of prescription patterns of cancer medications during periods of drug stockouts in Botswana
por: Davey, Sonya, et al.
Publicado: (2021) -
Breast Cancer Pathology Turnaround Time in Botswana
por: Martei, Yehoda M., et al.
Publicado: (2017) -
Availability of WHO Essential Medicines for Cancer Treatment in Botswana
por: Martei, Yehoda M., et al.
Publicado: (2018) -
Methodology to Forecast Volume and Cost of Cancer Drugs in Low- and Middle-Income Countries
por: Martei, Yehoda M., et al.
Publicado: (2018)